Minerva Neurosciences, Inc.

NERV ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014 FY2013
Assets
Cash & Equivalents $26.1M $83.0M $14.3M $18.5M $1.8M
Accounts Receivable — — — — —
Inventory — — — — —
Total Current Assets $129.5M $83.9M $33.5M $19.3M $1.8M
Property, Plant & Equipment $50.9K $9.6K $26.2K $43.4K $3.2K
Goodwill $14.9M $14.9M $14.9M $14.9M $7.9M
Intangible Assets (Excl. Goodwill) $34.2M $34.2M $34.2M $34.2M $19.0M
Total Assets $183.7M $132.9M $82.6M $68.5M $29.2M
Liabilities
Accounts Payable $1.4M $1.5M $1.4M $641.8K $523.0K
Total Current Liabilities $6.8M $9.7M $5.3M $3.5M $1.4M
Long-Term Debt — — — — —
Total Liabilities $52.1M $27.0M $27.3M $17.0M $9.0M
Stockholders' Equity
Retained Earnings $-164.4M $-132.9M $-101.8M $-74.7M $-17.8M
Total Stockholders' Equity $131.6M $106.0M $55.3M $51.5M $20.2M
← Newer Page 2 of 2 Older →